Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.

Robbert Gerard BentvelsenAndreas L E Van ArkelTom A RijpstraMerijn K M KantSimone Van Der Sar-Van Der BruggeDaan W LothPeter Van WijngaardenArthur W F Du MéeDavid C Y YickBram M W DiederenPeter C WeverAlexander C A P LeendersLaura Van DommelenKlaas H De GrootWouter Van den BijllaardtPaul E Verweij

Published in: Journal of fungi (Basel, Switzerland) (2022)

The high incidence of possible and probable CAPA in critically ill COVID-19 patients is alarming. The increase in 30-day mortality in CAPA highlights the need for active surveillance and management strategies in critically ill COVID-19 patients.

Keyphrases

sars cov
risk factors
coronavirus disease
respiratory syndrome coronavirus
pulmonary hypertension
cardiovascular events
cardiovascular disease
coronary artery disease